Clinical Trial Update: Omega-3 Fatty Acid Supplementation in Children [Phase 2]

View source ↗

Summary

Phase 2 study of omega-3 fatty acid supplementation in children with chronic kidney disease and hypertriglyceridemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertriglyceridemia

Drugs mentioned

• Omega-3 Fatty Acid Supplement (omega-3 fatty acids)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Chronic Kidney Disease, Hypertriglyceridemia | Phase 2 | Status: COMPLETED